Based on a large cohort of patients, derived from the integration of four independent genome-wide studies in bladder cancer, our analysis (Figure 2) distinguishes NOTCH3 mutations in non-muscle-invasive bladder cancer [61] from muscle-invasive cases [53,62,91,92]. The gene discussed is NOTCH3; the disease is urinary bladder cancer.